170 related articles for article (PubMed ID: 29031512)
1. Current antiviral drugs and their analysis in biological materials - Part II: Antivirals against hepatitis and HIV viruses.
Nováková L; Pavlík J; Chrenková L; Martinec O; Červený L
J Pharm Biomed Anal; 2018 Jan; 147():378-399. PubMed ID: 29031512
[TBL] [Abstract][Full Text] [Related]
2. Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses.
Nováková L; Pavlík J; Chrenková L; Martinec O; Červený L
J Pharm Biomed Anal; 2018 Jan; 147():400-416. PubMed ID: 28755849
[TBL] [Abstract][Full Text] [Related]
3. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
Bottecchia M; Garcia-Samaniego J; Soriano V
Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus and HIV infection.
Martín-Carbonero L; Poveda E
Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650
[TBL] [Abstract][Full Text] [Related]
5. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
Hofmann WP; Soriano V; Zeuzem S
Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
[TBL] [Abstract][Full Text] [Related]
6. Achievements and challenges in antiviral drug discovery.
Littler E; Oberg B
Antivir Chem Chemother; 2005; 16(3):155-68. PubMed ID: 16004079
[TBL] [Abstract][Full Text] [Related]
7. Future antivirals-SMi conference: latest developments in HIV, hepatitis, herpes, influenza, RSV and SARS.
Harrison R
IDrugs; 2004 Jan; 7(1):34-6. PubMed ID: 14968814
[No Abstract] [Full Text] [Related]
8. [Human immunodeficiency virus infection and viral hepatitis].
Soriano V; Martin-Carbonero L; Vispo E; Labarga P; Barreiro P
Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):691-701. PubMed ID: 21978797
[TBL] [Abstract][Full Text] [Related]
9. [The Past and Future of Hepatitis B Virus, Hepatitis C Virus, and Human Immunodeficiency Virus Infection].
Hayashi J
Rinsho Byori; 2015 Jun; 63(6):746-7. PubMed ID: 26548239
[TBL] [Abstract][Full Text] [Related]
10. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.
Coffin CS; Osiowy C; Myers RP; Gill MJ
J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393
[TBL] [Abstract][Full Text] [Related]
11. Antivirals: past, present and future.
De Clercq E
Biochem Pharmacol; 2013 Mar; 85(6):727-44. PubMed ID: 23270991
[TBL] [Abstract][Full Text] [Related]
12. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
13. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Rockstroh JK
Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
Townsend K; Meissner EG; Sidharthan S; Sampson M; Remaley AT; Tang L; Kohli A; Osinusi A; Masur H; Kottilil S
AIDS Res Hum Retroviruses; 2016 May; 32(5):456-62. PubMed ID: 26559180
[TBL] [Abstract][Full Text] [Related]
15. Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
Susser S; Flinders M; Reesink HW; Zeuzem S; Lawyer G; Ghys A; Van Eygen V; Witek J; De Meyer S; Sarrazin C
Antimicrob Agents Chemother; 2015 May; 59(5):2746-55. PubMed ID: 25712364
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry.
Brown RS; Verna EC; Pereira MR; Tilson HH; Aguilar C; Leu CS; Buti M; Fagan EA
J Hepatol; 2012 Nov; 57(5):953-9. PubMed ID: 22766470
[TBL] [Abstract][Full Text] [Related]
17. Editorial commentary: Management of hepatitis C Virus in HIV-infected patients in the era of direct-acting antivirals.
Zeremski M; Martinez AD; Talal AH
Clin Infect Dis; 2014 Mar; 58(6):880-2. PubMed ID: 24336913
[No Abstract] [Full Text] [Related]
18. Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.
Salazar-Vizcaya L; Kouyos RD; Zahnd C; Wandeler G; Battegay M; Darling KE; Bernasconi E; Calmy A; Vernazza P; Furrer H; Egger M; Keiser O; Rauch A;
Hepatology; 2016 Dec; 64(6):1856-1869. PubMed ID: 27531615
[TBL] [Abstract][Full Text] [Related]
19. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
20. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
Cheruvu S; Marks K; Talal AH
Clin Liver Dis; 2007 Nov; 11(4):917-43, ix-x. PubMed ID: 17981235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
